Compliance with galantamine and vitamin E in Alzheimer's disease patients: The care trial.

被引：0
|
作者：
Feely, M
Amatniek, J
机构：
[1] Acad Unit Mol Vasc Med, Leeds, W Yorkshire, England
[2] Janssen Pharmaceut Prod, LP, Titusville, NJ USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2003年 / 51卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P184
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of galantamine in Alzheimer's disease: A naturalistic study of 191 patients
    Croisile, BJ
    Neuschwander, P
    Boiste, M
    Bernachot, V
    Dantin, G
    NEUROBIOLOGY OF AGING, 2004, 25 : S201 - S202
  • [42] Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease
    Cummings, JL
    Schneider, L
    Tariot, PN
    Kershaw, PR
    Yuan, WY
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03): : 532 - 538
  • [43] The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer's Disease
    Ohnishi, Takashi
    Sakiyama, Yojiro
    Okuri, Yuichi
    Kimura, Yuji
    Sugiyama, Nami
    Saito, Takayuki
    Takahashi, Masayoshi
    Kobayashi, Takumi
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (02) : 110 - 118
  • [44] Switching, strategy with galantamine in the treatment of patients with mild to moderate Alzheimer's disease
    Hwang, T-Y.
    Ahn, I-S.
    Yun, J.
    Kim, S.
    Kim, D. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 172 - 172
  • [45] Galantamine offers significant benefits for patients with very mild Alzheimer's disease
    Orgogozo, JM
    Hammond, G
    Schwalen, S
    Kershaw, P
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 269 - 270
  • [46] Medication compliance in Singaporean patients with Alzheimer's disease
    Lum, Zheng Kang
    Suministrado, Ma Serrie P.
    Venketasubramanian, N.
    Ikram, M. Kamran
    Chen, Christopher
    SINGAPORE MEDICAL JOURNAL, 2019, 60 (03) : 154 - 160
  • [47] Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine
    Lopez-Pousa, Secundino
    Olmo, Josep Garre
    Franch, Joan Vilalta
    Estrada, Antoni Turon
    Cors, Olga Soler
    Nierga, Imma Pericot
    Gerada-Batlle, Esther
    AGE AND AGEING, 2006, 35 (04) : 365 - 371
  • [48] PREDICTORS OF OUTCOME IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE TREATED WITH GALANTAMINE
    Richarz, U.
    Gaudig, M.
    Adami, M.
    Jacobs, A.
    Schreiner, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 354 - 354
  • [49] Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease
    Vellas, B
    Cunha, L
    Gertz, HJ
    De Deyn, PP
    Wesnes, K
    Hammond, G
    Schwalen, S
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) : 1423 - 1429
  • [50] Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine
    Capella, Dolors
    Vidal, Xavier
    AGE AND AGEING, 2007, 36 (02) : 234 - 234
12345